卡斯波金可以增强里法素对抗格拉姆阴性细菌的功效
Haotian Li1,2, Xiaojing Zhu1,2, Xing Zhang1,2
1School of Pharmaceutical Sciences, Wuhan University, Wuhan, China.
Frontiers in microbiology
|August 30, 2024
概括
素酸 (CAS) 作为抗生素辅助剂对抗格兰氏阴性细菌 (GNB). CAS增强了抗生素的有效性,并减缓了耐药性的发展,提供了一种新的抗感染策略.
科学领域:
- 微生物学 微生物学
- 药物发现 药物发现 药物发现
- 抗微生物耐药性 抗微生物耐药性
背景情况:
- 抗菌素耐药性 (AMR) 是一个日益增长的威胁.
- 格拉姆阴性细菌 (GNB) 具有防护外,阻碍抗生素进入.
- 抗生素辅助剂对于克服AMR至关重要.
研究的目的:
- 识别针对GNB的新型抗生素辅助剂.
- 评估酸 (CAS) 作为辅助剂的潜力.
主要方法:
- 对3158种FDA批准的药物进行药物改用.
- 在体外的棋盘测试和体内Galleria mellonella感染模型.
- 耐药性发展测试,RNA-seq和酶测试.
主要成果:
- CAS被确定为辅助剂,增强对GNB的里法和胆固醇活性.
- 在体内,CAS增强了对抗多抗药性大肠杆菌的利法的疗效.
- CAS显示抗药性发展的加速减少,并揭示了包括细胞包膜透和PgaC抑制在内的机制.
结论:
- 酸 (CAS) 是一种可行的抗生素辅助剂,可以对抗阴性细菌.
- CAS为抗感染疗法提供了一个有前途的替代策略.
- 这项研究突出了药物重新定位的潜力,以发现新的辅助剂.
相关概念视频
Combined Effects of Drugs: Synergism
3.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.8K
Dose-Response Relationship: Potency and Efficacy
4.3K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
4.3K


